Paul Tudor Jones Anika Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

$25.1 Billion
Q4 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 35,989 shares of ANIK stock, worth $547,392. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,989

Previous 29,342 22.65%

Holding current value

$547,392

Previous $724,000 18.23%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$16.04 - $25.53 $106,617 - $169,697	6,647 Added 22.65%	35,989 $592,000
Q3 2024 Nov 14, 2024	BUY	$24.25 - $28.75 $17,338 - $20,556	715 Added 2.5%	29,342 $724,000
Q2 2024 Aug 14, 2024	SELL	$24.57 - $28.47 $182,309 - $211,247	-7,420 Reduced 20.58%	28,627 $725,000
Q1 2024 May 15, 2024	BUY	$21.95 - $26.42 $256,507 - $308,744	11,686 Added 47.97%	36,047 $915,000
Q4 2023 Feb 14, 2024	SELL	$18.47 - $23.3 $215,544 - $271,911	-11,670 Reduced 32.39%	24,361 $552,000
Q3 2023 Nov 15, 2023	BUY	$16.98 - $26.1 $611,806 - $940,409	36,031 New	36,031 $671,000
Q2 2021 Aug 16, 2021	SELL	$39.42 - $48.08 $1.31 Million - $1.6 Million	-33,185 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$32.49 - $45.96 $511,002 - $722,858	15,728 Added 90.1%	33,185 $1.35 Million
Q4 2020 Feb 16, 2021	BUY	$32.59 - $45.26 $167,121 - $232,093	5,128 Added 41.59%	17,457 $790,000
Q3 2020 Nov 16, 2020	BUY	$32.56 - $38.57 $401,432 - $475,529	12,329 New	12,329 $436,000
Q1 2020 May 15, 2020	SELL	$22.38 - $54.06 $687,110 - $1.66 Million	-30,702 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$51.85 - $73.36 $669,642 - $947,444	12,915 Added 72.61%	30,702 $1.59 Million
Q3 2019 Nov 14, 2019	BUY	$40.05 - $57.47 $440,590 - $632,227	11,001 Added 162.11%	17,787 $976,000
Q2 2019 Aug 14, 2019	BUY	$30.3 - $41.14 $205,615 - $279,176	6,786 New	6,786 $276,000
Q2 2018 Aug 14, 2018	SELL	$28.77 - $48.27 $278,694 - $467,591	-9,687 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$49.22 - $68.43 $325,048 - $451,911	-6,604 Reduced 40.54%	9,687 $482,000
Q4 2017 Feb 14, 2018	SELL	$52.14 - $59.94 $143,437 - $164,894	-2,751 Reduced 14.45%	16,291 $878,000
Q3 2017 Nov 14, 2017	BUY	$51.16 - $58.21 $974,188 - $1.11 Million	19,042	19,042 $1.1 Million

Others Institutions Holding ANIK

# of Institutions

111

Shares Held

11.1M

Call Options Held

1.8K

Put Options Held

1.9K

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $222M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account